Cancer

Scientists Link New Cancer Treatments to Cardiovascular Alterations

by Spanish National Cancer Research Centre Plk1 inhibitors have recently been acknowledged as an "Innovative Therapy for leukemia" by the US Food and Drug Administration (FDA). However, a study published in Nature Medicine by researchers from the Spanish National Cancer Research Centre (CNIO) suggests that prolonged use of these inhibitors can not only lead to

FDA Approves Novel Leukemia Treatment that Could Be First U.S. Gene Therapy

By Linda Johnson, Associated Press A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations from

July 19th, 2017|Categories: Cancer, Uncategorized|Tags: , , |

F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment

The New York Times By DENISE GRADY A Food and Drug Administration panel opened a new era in medicine on Wednesday, unanimously recommending that the agency approve the first-ever treatment that genetically alters a patient’s own cells to fight cancer, transforming them into what scientists call “a living drug” that powerfully bolsters the immune system

July 14th, 2017|Categories: Cancer, Disease Specific|Tags: , , , , |

Blood Test Detects Ovarian Cancer in Study

LONDON (Reuters) - British liquid biopsy company Angle said its Parsortix blood test had beaten current methods in identifying ovarian cancer, a breakthrough that could help women receive the best possible outcome from surgery. Topline results from a study of 400 patients in Europe and the United States showed the test to detect cancerous cells

July 9th, 2017|Categories: Cancer|Tags: , , , |

Blood Test to Target Prostate Cancer Treatment

A new 3-in-1 blood test could revolutionise the treatment of prostate cancer, say scientists, and help pave the way for personalised patient treatment. The key to the new treatment is the ability to test for cancer DNA in a person's bloodstream. This so-called 'liquid biopsy' has the advantage of being cheaper and less invasive than

June 27th, 2017|Categories: Cancer, Uncategorized|Tags: , , |

Death Rate From Liver Cancer in US Now Double That in 1980s

Mortality rates from liver cancer in the United States have doubled since the mid-1980s, and they are increasing faster than for any other cancer, according to a new analysis by the American Cancer Society. The study was published online June 7 in CA: A Cancer Journal for Clinicians. From 2009 to 2013, the average incidence

June 17th, 2017|Categories: Cancer|Tags: , |

Liquid Biopsies: Too Soon for Cancer Detection

While the idea of using a drop of blood to detect an occult cancer is still elusive, use of so-called liquid biopsies for cancer screening is at least a little closer to reality with the development of a new high-intensity genomic sequencing approach outlined here at the American Society of Clinical Oncology (ASCO) 2017 Annual

June 15th, 2017|Categories: Cancer|Tags: , , , |

Novel Surgical Technique Paves Way to Restoring Failing Organs

UCSF Study Shows Strategy May Boost Survival of Transplanted Stem Cells By Suzanne Leigh on May 14, 2017 By piercing liver cells with rapid pulses of electricity, scientists at UC San Francisco have demonstrated an entirely new way to transplant cells into organs to treat disease. Because the technique provides a hospitable environment for newly